On Fisher Consistency of Surrogate Losses for Optimal Dynamic Treatment Regimes with Multiple Categorical Treatments per Stage
Nilanjana Laha, Nilson Chapagain, Victoria Cicherski, Aaron Sonabend-W

TL;DR
This paper investigates the Fisher consistency of surrogate losses in learning optimal dynamic treatment regimes with multiple stages and treatments, providing theoretical conditions and proposing a new algorithm, SDSS, with practical validation.
Contribution
It establishes necessary and sufficient conditions for Fisher consistency of surrogate losses in multi-stage, multi-treatment DTRs and introduces SDSS, a novel algorithm using non-concave surrogates for improved learning.
Findings
Many convex surrogates are Fisher inconsistent for DTRs.
SDSS effectively learns optimal DTRs with theoretical regret bounds.
Empirical results demonstrate SDSS's practical utility in healthcare data.
Abstract
Patients with chronic diseases often receive treatments at multiple time points, or stages. Our goal is to learn the optimal dynamic treatment regime (DTR) from longitudinal patient data. When both the number of stages and the number of treatment levels per stage are arbitrary, estimating the optimal DTR reduces to a sequential, weighted, multiclass classification problem (Kosorok and Laber, 2019). In this paper, we aim to solve this classification problem simultaneously across all stages using Fisher consistent surrogate losses. Although computationally feasible Fisher consistent surrogates exist in special cases, e.g., the binary treatment setting, a unified theory of Fisher consistency remains largely unexplored. We establish necessary and sufficient conditions for DTR Fisher consistency within the class of non-negative, stagewise separable surrogate losses. To our knowledge, this is…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
